Dr Sreelekha Rajesh appointed as the first dean Maharashtra University of Health Sciences (MUHS) has officially established Nursing as an independent faculty. This landmark achievement not only reshapes the academic landscape in Maharashtra but also recognises the pivotal role nurses play in healthcare. Dr Sreelekha Rajesh has been appointed as the first dean of the Nursing Faculty at MUHS, marking a momentous milestone in nursing education.  Dr Sreelekha currently serves as the Professor cum Vice Principal at GMF Tehmi Grant Institute of Nursing Education (Ruby Hall Clinic, Pune). With ..read more

WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission intensity A new vaccine for dengue received prequalification from the World Health Organization (WHO). TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue.  WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission intensity. The vaccine should be administered in a two ..read more

Achira is engaged in the development and commercialisation of point-of-care (PoC) medical test kits in India Cipla has signed definitive agreements for further investment of up to Rs 26 crore (approx) in Optionally Convertible Preference Shares of Achira Labs, an associate company in four tranches, subject to completion of certain milestones. Achira is engaged in the development and commercialisation of point-of-care (PoC) medical test kits in India. Since Cipla’s previous investment in June 2022, Achira has made significant developments in the Product Development and R&D space. Under the ..read more

The partnership has focussed on the core mission of delivering advanced and affordable medical devices globally HostBooks has successfully implemented its ERP solutions at UnivLabs Technologies, a leading medical equipment manufacturing company based in Gurgaon. Girish Belekar, Head of Product Delivery at HostBooks, led the implementation, along with Mritunjay Kumar, Manager of Implementation and the team. UnivLabs, an integrated, research-based medical equipment manufacturing company, focuses on making advanced medical devices accessible and affordable globally. Their innovative range includ ..read more

The two strategically located centres will commence operations in early 2025 Healthcare Global Enterprises (HCG) is expanding its footprint in Bengaluru with the launch of its two new state-of-the-art, comprehensive cancer care centres in Whitefield and North Bengaluru. There are plans to extend specialised and advanced modes of cancer treatment to these two highly populated neighbourhoods in the city, making them the third and fourth in its hospital network in Bengaluru. The two strategically located centres will commence operations in early 2025.  Both facilities will provide the entir ..read more

As world’s First ‘IFC-EDGE Advanced’ certified speculative life sciences building Rx Propellant, India’s leading life sciences infrastructure platform, has announced that 3GV, one of its pharma and life sciences facilities located at Genome Valley, Hyderabad, has secured the distinction of being the first ‘IFC-EDGE Advanced’ Certified Speculative Life Sciences Building, globally. Rx Propellant has a proven track record of delivering specialized life science real estate projects across India with current portfolio in Hyderabad, Bengaluru, and Mumbai. The company has taken t ..read more

The company will primarily utilise the investment from KSSF II to set up a new manufacturing plant Kotak Strategic Situations India Fund II, managed by Kotak Alternate Asset Managers (Kotak Alt), announced an investment of up to Rs 400 crore in Biorad Medisys.   Biorad Medisys is a leading medical device manufacturer. The company will primarily utilise the investment from KSSF II to set up a new manufacturing plant, repay existing debt and fund increasing working capital requirements.  Eshwar Karra, CEO, Kotak Strategic Situations India Fund ..read more

The investment from ChrysCapital, which is a mix of primary and secondary, will support CFS in accelerating its expansion plans and will also provide an exit for MHL ChrysCapital is investing up to $100 million in New Delhi Centre for Sight, based out of New Delhi. The transaction involves a mix of primary infusion and purchase of the entire stake held by Mahindra Holdings, a wholly-owned subsidiary of Mahindra & Mahindra for acquiring a significant minority stake in the company. The investment will support CFS’s ability to further scale and serve the growing demand for eye care in I ..read more

The centre will offer a wide array of services including injury prevention programmes, advanced diagnostics, personalised rehabilitation plans and sports nutrition counselling CARE Hospitals has opened its cutting-edge Sports Medicine and Rehabilitation Centre at its Banjara Hills Unit. The facility which heralds a new era in specialised healthcare for athletes and active individuals was inaugurated by SunRisers Hyderabad cricketers – Heinrich Klaasen, Marco Jansen, Nitish Kumar Reddy and Shahbaz Ahamad, in the presence of Varun Khanna – Group Managing Director, Quality Care India, Jasdeep Si ..read more

Focussed on AI-EMC Design Synthetics in its portfolio Elfonze Technologies, a pioneer in enterprise, digital and connected supply chain services is excited to announce the successful merger of iAMPS & Hz’s business unit AI-EMC Design Synthetics as part of the ongoing efforts to enhance and expand service offerings.  iAMPS & Hz is renowned in the field of Electromagnetic Compatibility, offering specialised services in design, simulation, verification, validation, certification, and calibration. Known for pioneering approaches, the company delivers impactfu ..read more